Ionis Pharmaceuticals (IONS) PT Raised to $69 at Citi
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $54.21 -2.59%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Citi analyst David Lebowitz raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $69.00 (from $65.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- Cronos Group extends cannabis acquisition deadline to October 2026
- BetterLife Pharma files final prospectus for $100M public offering
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Citi, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
